Analysts/Institutional Investor Meet/Con. Call Updates

October 22, 2026 The National Stock Exchange of India Limited BSE Limited Exchange Plaza Phiroze Jeejeebhoy Towers (CS-1Y,M BBloOcLk :G T, HBaYnRdOrCa AKRuErl)a Comple x, (DSaClRalI PSt CreOeDt, E: 539871) Bandra (E), Mumbai - 400 051 Mumbai – 400 001 Sub : Invite for Earnings Conference Call Ref : Regulation 30 read with Para A of Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“SEBI Listing Regulations”) Dear Sir/Madam, Pursuant to Regulation 30 read with Para A of Part A of Schedule III of the SEBI Listing Regulations, we wish to inform you that a conference call for analysts/investors has been scheduled to discuss the Unaudited Financial Results of the Company for the quarter and half year ended September 30, 2026, on Thursday, October 29, 2026 at 06:00 PM (IST). Dial-in details are given in the copy of the enclosed invite. This is for your information and records. T hyrocare Technologies Limited Yours faithfully, Brijesh Kumar Company Secretary and Compliance Officer E ncl.: As above Q2 FY2026-27 Earnings Call Thursday, October 29, 2026, 06:00 PM (IST) Thyrocare Technologies Limited Invites you to interact with the Senior Management on Q2 FY2026-27 earnings Speakers Mr. Rahul Guha, Chairman, MD & CEO Mr. Rajdeep Panwar, CCO Dr. Ramesh Kinha, COO Mr. Vikram Gupta, CFO Mr. Prinesh Parikh, DGM - Strategy & Investor Relations Conference Call Details Dial in Details: For Thyrocare’s Conference Call, Thursday, October 29, 2026, 06:00 PM (IST) +91 22 6280 1408 Universal Access +91 22 7115 8296 Copy this URL in your browser https://services.choruscall.in/DiamondPassRegistration/register?confirmationNum (for early registration) ber=0980112&linkSecurityString=88dab63a0 Webcast Link https://event.choruscall.com/mediaframe/webcast.html?webcastid=9AzRRnHy